The "Goldilocks Zone" for Share Buybacks--Beware Excess!

A backtest covering 227,000 12-month holding periods from 1998-2025 found companies reducing share counts by at least 5% annually outperformed sector peers by nearly 3 percentage points per year and won in 70% of measured quarters. The analysis identifies a 5%-10% annual share-count reduction as the buyback "sweet spot," while companies increasing share counts by more than 5% lagged peers in roughly three of five quarters. Aflac is highlighted as an example, with its share count down 6.3% over the past year and Q2 capital returns of $983M in buybacks plus $309M in dividends, equivalent to an annualized 8.9% of market capitalization.

Analysis

AFL’s capital-return profile supports downside resilience, but the investable question is whether repurchases are being funded by recurring excess capital rather than favorable currency translation or a temporarily loose reserve/capital position. For an insurer, the relevant constraint is statutory/RBC capital and Japan subsidiary dividend capacity, not simply consolidated free cash flow. A sustained reduction in share count can compound EPS even with modest premium growth, but that mechanism weakens sharply if claim costs, investment losses, or regulatory capital requirements force management to slow repurchases.

The second-order opportunity is relative: AFL should screen better than insurers using buybacks primarily to offset stock compensation or those facing more volatile catastrophe exposure. However, the market already tends to reward predictable capital return in large-cap financials; upside requires either a higher terminal multiple from lower perceived Japan/FX risk or EPS revisions from better-than-expected investment income and benefits experience. Over the next 1-3 months, quarterly disclosure of actual repurchases, book-value growth, and RBC metrics matters more than authorization headlines.

Contrarian risk is that a mechanically attractive payout yield can mask valuation-sensitive capital allocation. If AFL repurchases aggressively after a material share-price rerating, each dollar retires less EPS and reduces flexibility for bolt-on growth, reserve strengthening, or a Japanese capital-market shock. The historical buyback factor is useful as a screen, not a standalone causal forecast: companies often buy back most heavily when operating conditions and balance sheets are already unusually strong.

Key Decisions for Investors

• Maintain or initiate a modest long AFL versus a short in a more catastrophe-sensitive P&C insurer basket over 3-6 months; the thesis is superior capital-return durability rather than a broad insurance beta call. Target 8-12% total return, with relative-risk reduction if AFL’s next reported quarterly repurchase pace falls materially below its recent run rate.
• Do not chase a buyback narrative on authorization alone: add only after the next earnings release confirms continued net share-count reduction, stable statutory/RBC capital, and no adverse reserve development. Those three data points are the gating variables for a higher-conviction position.
• Use a downside trigger rather than a naked options expression: reassess the long if management cuts full-year capital-return guidance, Japanese subsidiary upstreaming is constrained, or investment/benefit experience drives a meaningful EPS-guide reduction. Any of these would impair the compounding mechanism before it is visible in reported share count.
• For financial-factor exposure, prefer a basket of verified net-share reducers with conservative leverage over high-yield issuers whose payouts consume most free cash flow; require dilution from equity compensation to be netted against gross buybacks before inclusion.